Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2569-2577

  Boussioutas, Alex ^a,d,e   Li, Hong ^b   Liu, Jia ^b   Waring, Paul ^a   Lade, Stephen ^a   Holloway, Andrew J ^a   Taupin, Douglas ^c   Gorringe, Kylie ^a   Haviv, Izhak ^a   Desmond, Paul V ^d,e   Bowtell, David D L ^a,e  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c CANBERRA HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER GROWTH; CARCINOGENESIS; CHINESE; CHRONIC GASTRITIS; CONTROLLED STUDY; DNA MICROARRAY; ETHNIC GROUP; FEMALE; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 0038576352     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Livingstone, J. I., Yasui, W., Tahara, E., and Wastell, C. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br. J. Cancer, 72: 976-980, 1995.
2. McCulloch, P. G., Ochiai, A., O'Dowd, G. M., Nash, J. R., Sasako, M., and Hirohashi, S. Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan. Cancer (Phila.), 75: 920-925, 1995.
3. McCulloch, P., Taggart, T., Ochiai, A., O'Dowd, G., Nash, J., and Sasako, M. c-erhB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur. J. Surg. Oncol., 23: 304-309, 1997.
4. Hundahl, S. A., Phillips, J. L., and Menck, H. R. The National Cancer Data Base Report on poor survival of U. S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer, 88: 921-932, 2000.
5. Rembacken, B., Fujii, T., and Kondo, H. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Pract. Res. Clin. Gastroenterol., 15: 317-336, 2001.
6. Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path. Microbiol. Scand., 64: 31-49, 1965.
7. Ming, S. C. Gastric carcinoma. A pathobiological classification. Cancer, 39: 2475-2485, 1977.
8. Hughes, N. R., and Bhathal, P. S. Gastric mucous neck cell and intestinal goblet cell phenotypes in gastric adenocarcinoma. J. Clin. Pathol. 50: 741-748, 1997.
9. Park, W. S., Oh, R. R., Park, J. Y., Lee, S. H., Shin, M. S., Kim, Y. S., Kim, S. Y., Lee, H. K., Kim, P. J., Oh, S. T., Yoo, N. J., and Lee, J. Y. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res., 59: 4257-4260, 1999.
10. Berx, G., Becker, K. F., Hofler, H., and van Roy, F. Mutations of the human E-cadherin (CDH1) gene. Hum. Mutat., 12: 226-237, 1998.
11. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., and Reeve, A. E. E-cadherin germline mutations in familial gastric cancer. Nature (Lond.), 392: 402-405, 1998.
12. Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng. C., Park, J. G., Kim, S. J., and Markowitz, S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet., 26: 16-17, 2000.
13. Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., and Sitas, F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ, 302: 1302-1305, 1991.
14. Parsonnet, J., Vandersteen, D., Goates, J., Sibley, R. K., Pritikin, J., and Chang, Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas [Published erratum appears in J. Natl. Cancer Inst. (Bethesda), 83: 881, 1991]. J. Natl. Cancer Inst. (Bethesda), 83: 640-643, 1991.
15. Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S., and Archer, M. A model for gastric cancer epidemiology. Lancet, 2: 58-60, 1975.
16. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res., 52: 6735-6740, 1992.
17. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
18. Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C., Lashkari, D., Shalon, D., Brown, P. O., and Botstein, D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA, 96: 9212-9217, 1999.
19. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., and Botstein, D. Molecular portraits of human breast tumours. Nature (Lond.), 406: 747-752, 2000.
20. Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y., Goumnerova, L. C., Black, P. M., Lau, C., Allen, J. C., Zagzag, D., Olson, J. M., Curran, T., Wetmore, C., Biegel, J. A., Poggio, T., Mukherjee, S., Rifkin, R., Califano, A., Stolovitzky, G., Louis, D. N., Mesirov, J. P., Lander, E. S., and Golub, T. R. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (Lond.), 415: 436-442, 2002.
21. El-Rifai, W., Frierson, H. F., Jr., Harper, J. C., Powell, S. M., and Knuutila, S. Expression profiling of gastric adenocarcinoma using cDNA array. Int. J. Cancer, 92: 832-838, 2001.
22. Hippo, Y., Taniguchi, H., Tsutsumi, S., Machida, N., Chong, J. M., Fukayama, M., Kodama, T., and Aburatani, H. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res., 62: 233-240, 2002.
23. Israel, D. A., Salama, N., Arnold, C. N., Moss, S. F., Ando, T., Wirth, H. P., Tham, K. T., Camorlinga, M., Blaser, M. J., Falkow, S., and Peek, R. M., Jr. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Investig., 107: 611-620, 2001.
24. Inoue, H., Matsuyama, A., Mimori, K., Ueo, H., and Mori, M. Prognostic score of gastric cancer determined by cDNA microarray. Clin. Cancer Res., 8: 3475-3479, 2002.
25. Sakakura, C., Hagiwara, A., Nakanishi, M., Shimomura, K., Takagi, T., Yasuoka, R., Fujita, Y., Abe, T., Ichikawa, Y., Takahashi, S., Ishikawa, T., Nishizuka, I., Morita, T., Shimada, H., Okazaki, Y., Hayashizaki, Y., and Yamagishi, H. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br. J. Cancer, 87: 1153-1161, 2002.
26. Hasegawa, S., Furukawa, Y., Li, M., Satoh, S., Kato, T., Watanabe, T., Katagiri, T., Tsunoda, T., Yamaoka, Y., and Nakamura, Y. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res., 62: 7012-7017, 2002.
27. Leung, S. Y., Chen, X., Chu, K. M., Yuen, S. T., Mathy, J., Ji, J., Chan, A. S., Li, R., Law, S., Troyanskaya, O. G., Tu, I., P., Wong, J., So, S., Botstein, D., and Brown, P. O. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc. Natl. Acad. Sci. USA, 99: 16203-16208, 2002.
28. Varis, A., Wolf, M., Monni, O., Vakkari, M. L., Kokkola, A., Moskaluk, C., Frierson, H., Jr., Powell, S. M., Knuutila, S., Kallioniemi, A., and El-Rifai, W. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res., 62: 2625-2629, 2002.
29. Khan, J., Simon, R., Bittner, M., Chen, Y., Leighton, S. B., Pohida, T., Smith, P. D., Jiang, Y., Gooden, G. C., Trent, J. M., and Meltzer, P. S. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res., 58: 5009-5013, 1998.
30. Key, G., Petersen, J. L., Becker, M. H., Duchrow, M., Schluter, C., Askaa, J., and Gerdes. J. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J. Clin. Pathol., 46: 1080-1084, 1993.
31. Shimoyama, Y., and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51: 2185-2192, 1991.
32. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
33. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J., and Speed, T. P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res., 30: e15, 2002.
34. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 95: 14863-14868, 1998.
35. Benjamini, Y. H. Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc., 57: 289-300, 1995.
36. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R. J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med., 345: 784-789, 2001.
37. Yu, J., Leung, W. K., Go, M. Y., Chan, M. C., To, K. F., Ng, E. K., Chan, F. K., Ling, T. K., Chung, S. C., and Sung, J. J. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut, 51: 480-484, 2002.
38. Peek, R. M., Jr., and Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer, 2: 28-37, 2002.
39. van Doom, L. J., Figueiredo, C., Sanna, R., Plaisier, A., Schneeberger, P., de Boer, W., and Quint, W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology, 115: 58-66, 1998.
40. Parsonnet, J., Friedman, G. D., Orentreich, N., and Vogelman, H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40: 297-301, 1997.
41. Odenbreit, S., Puls, J., Sedlmaier, B., Gerland, E., Fischer, W., and Haas, R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science (Wash. DC), 287: 1497-1500, 2000.
42. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., and Hatakeyama, M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science (Wash. DC), 295: 683-686, 2002.
43. Kimura, M., Goto, S., Wada, A., Yahiro, K., Niidome, T., Hatakeyama, T., Aoyagi, H., Hirayama, T., and Kondo, T. Vacuolating cytotoxin purified from Helicobacter pylori causes mitochondrial damage in human gastric cells. Microb. Pathog., 26: 45-52, 1999.
44. Galmiche, A., Rassow, J., Doye, A., Cagnol, S., Chambard. J. C., Contamin, S., de Thillot, V., Just, I., Ricci, V., Solcia, E., Van Obberghen, E., and Boquet, P. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J., 19: 6361-6370, 2000.
45. Ianev, P., and Chifchinskii, S. Changes in the ultrastructure of parietal cells of gastric glands in chronic gastritis. Arkh. Patol., 40: 18-22, 1978.
46. Scott, D. R., Marcus, E. A., Weeks, D. L., and Sachs, G. Mechanisms of acid resistance due to the urease system of Helicobacter pylori. Gastroenterology, 123: 187-195, 2002.
47. Sepulveda, A. R., Tao, H., Carloni, E., Sepulveda, J., Graham, D. Y., and Peterson, L. E. Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment. Pharmacol. Ther., 16 (Suppl 2): 145-157, 2002.
48. Bach, S., Makristathis, A., Rotter, M., and Hirschl, A. M. Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative). Infect. Immunol., 70: 988-992, 2002.
49. Papini, E., Zoratti, M., and Cover, T. L. In search of the Helicobacter pylori VacA mechanism of action. Toxicon, 39: 1757-1767, 2001.
50. Park, W. S., Oh, R. R., Park, J. Y., Lee, J. H., Shin, M. S., Kim, H. S., Lee, H. K., Kim, Y. S., Kim, S. Y., Lee, S. H., Yoo, N. J., and Lee, J. Y. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology, 119: 691-698, 2000.
51. Lefebvre, O., Chenard, M. P., Masson, R., Linares, J., Dierich, A., LeMeur, M., Wendling, C., Tomasetto, C., Chambon, P., and Rio, M. C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science (Wash. DC), 274: 259-262, 1996.
52. Konturek, P. C., Konturek, S. J., Sulekova, Z., Meixner, H., Bielanski, W., Starzynska, T., Karczewska, E., Marlicz, K., Stachura, J., and Hahn, E. G. Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. Aliment. Pharmacol. Ther., 15: 989-999, 2001.
53. Kim, R., Ohi, Y., Inoue, H., and Toge, T. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers. Anticancer Res., 19: 5393-5398, 1999.
54. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D. CDC25 phosphatases as potential human oncogenes. Science (Wash. DC), 269: 1575-1577, 1995.
55. Nishioka, K., Doki, Y., Shiozaki, H., Yamamoto, H., Tamura, S., Yasuda, T., Fujiwara, Y., Yano, M., Miyata, H., Kishi, K., Nakagawa, H., Shamma, A., and Monden, M. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus. Br. J. Cancer, 85: 412-421, 2001.
56. Kudo, Y., Yasui, W., Ue, T., Yamamoto, S., Yokozaki, H., Nikai, H., and Tahara, E. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas. Jpn. J. Cancer Res., 88: 947-952, 1997.
57. Su, A. I., Welsh, J. B., Sapinoso, L. M., Kern, S. G., Dimitrov, P., Lapp, H., Schultz, P. G., Powell, S. M., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res., 61: 7388-7393, 2001.
58. Shaffer, A. L., Rosenwald, A., Hurt, E. M., Giltnane, J. M., Lam, L. T., Pickeral, O. K., and Staudt, L. M. Signatures of the immune response. Immunity, 15: 375-385, 2001.
59. Sage, E. H. Terms of attachment: SPARC and tumorigenesis. Nat. Med., 3: 144-146, 1997.
60. Le Bail, B., Faouzi, S., Boussarie, L., Guirouilh, J., Blanc, J. F., Carles, J., Bioulac-Sage, P., Balabaud, C., and Rosenbaum, J. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J. Pathol., 189: 46-52, 1999.
61. Ledda, M. F., Adris, S., Bravo, A. I., Kairiyama, C., Bover, L., Chemajovsky, Y., Mordoh, J., and Podhajcer, O. L. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat. Med., 3: 171-176, 1997.
62. Saitoh, T., Mine, T., and Katoh, M. Frequent up-regulation of WNT5A mRNA in primary gastric cancer. Int. J. Mol. Med., 9: 515-519, 2002.
63. Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., Glinka, A., and Niehrs, C. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature (Lond.), 417: 664-667, 2002.
64. Brott, B. K., and Sokol, S. Y. Regulation of Wnt/LRP Signaling by distinct domains of Dickkopf proteins. Mol. Cell. Biol., 22: 6100-6110, 2002.
65. Zorn, A. M. Wnt signalling: antagonistic Dickkopfs. Curr. Biol., 11: R592-R595, 2001.
66. Grotewold, L., and Ruther, U. The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. EMBO J., 21: 966-975, 2002.
67. Wang, Z., Tseng, C. P., Pong, R. C., Chen, H., McConnell, J. D., Navone, N., and Hsieh, J. T. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. J. Biol. Chem., 277: 12622-12631, 2002.
68. Mingchao, Devereux, T. R., Stockton, P., Sun, K., Sills, R. C., Clayton, N., Portier, M., and Flake, G. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp. Toxicol. Pathol., 53: 237-246, 2001.
69. Busch, C., Hanssen, T. A., Wagener, C., and O. Brink, B. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum. Pathol., 33: 290-298, 2002.
70. Kimura, Y., Shiozaki, H., Hirao, M., Maeno, Y., Doki, Y., Inoue, M., Monden, T., Ando-Akatsuka, Y., Furuse, M., Tsukita, S., and Monden, M. Expression of occludin, tight-junction-associated protein, in human digestive tract. Am. J. Pathol., 151: 45-54, 1997.